Scleroderma Trials in New Brunswick, United States
Conditions / Scleroderma / New Brunswick, United States
Clinical trials for Scleroderma investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02396238 | Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) | COMPLETED | NA |
| NCT00883129 | Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) | COMPLETED | PHASE2 |
| NCT00946699 | A Study of the Safety and Tolerability of MEDI-551 in Scleroderma | COMPLETED | PHASE1 |
| NCT02062125 | Calcinosis in a Single-Center Scleroderma Population | COMPLETED | — |
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | COMPLETED | PHASE2 |
| NCT00930683 | A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma | COMPLETED | PHASE1 |
| NCT00043706 | Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis | COMPLETED | PHASE1/PHASE2 |
| NCT00377949 | Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients | COMPLETED | — |
| NCT06195072 | Platform Clinical Study for Conquering Scleroderma | RECRUITING | PHASE2 |
| NCT00764309 | Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis | COMPLETED | PHASE1/PHASE2 |